Correlation Between Effector Therapeutics and Aravive
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Aravive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Aravive into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Aravive, you can compare the effects of market volatilities on Effector Therapeutics and Aravive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Aravive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Aravive.
Diversification Opportunities for Effector Therapeutics and Aravive
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Effector and Aravive is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Aravive in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aravive and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Aravive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aravive has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Aravive go up and down completely randomly.
Pair Corralation between Effector Therapeutics and Aravive
Given the investment horizon of 90 days Effector Therapeutics is expected to generate 2.01 times more return on investment than Aravive. However, Effector Therapeutics is 2.01 times more volatile than Aravive. It trades about -0.12 of its potential returns per unit of risk. Aravive is currently generating about -0.83 per unit of risk. If you would invest 1,925 in Effector Therapeutics on September 12, 2024 and sell it today you would lose (1,912) from holding Effector Therapeutics or give up 99.32% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 1.65% |
| Values | Daily Returns |
Effector Therapeutics vs. Aravive
Performance |
| Timeline |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Aravive |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Effector Therapeutics and Aravive Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Effector Therapeutics and Aravive
The main advantage of trading using opposite Effector Therapeutics and Aravive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Aravive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aravive will offset losses from the drop in Aravive's long position.| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |